The lawsuit, filed in the U.S. District Court for the Southern District of New York, centers on allegations that Alibaba provided materially misleading disclosures regarding its regulatory standing and internal AI practices. According to the complaint, the company failed to disclose that it met the statutory definition for a Chinese military company under the FY2025 NDAA, despite identifying similar risks for other issuers. This designation by the U.S. Department of Defense in June 2026 triggered initial selling pressure, which intensified following reports that Anthropic PBC accused the firm of illicitly accessing its Claude AI model.
Alibaba Investors Face October Deadline in Securities Class Action
Investors who purchased Alibaba Group Holding ADSs between June 26, 2025, and June 24, 2026, have until October 5, 2026, to seek lead plaintiff status in a pending class action lawsuit. The litigation follows a sharp 45% decline in share value linked to U.S. regulatory scrutiny and allegations of AI model misuse.
Market volatility throughout June 2026 saw the stock drop from a Class Period high of $173.68 to close at $95.07 on June 25. Joseph E. Levi of Levi & Korsinsky, the firm representing the class, argues that annual reports describing the "unauthorized distillation of third-party models" as a theoretical risk were deceptive, as the practice was already occurring. Shareholders seeking to recover losses are encouraged to compile brokerage records of their transactions during the specified period to participate in the case.
Comments (0)
No comments yet. Be the first!